May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Jonathon Carr-Brown, Chief Operating Officer at Healthily, shares how they are redefining the relationship between retailers and over-the-counter pharmaceutical companies with their customers, and how a digitally-enabled Pre-Primary Care Health…
Grab your beverage of choice and join us! This month, we’re diving into virtual product launches and pre-launch planning.
For this Pre-Product Launch Longitudinal Expert Engagement Plan™ (LEEP™), our client leveraged Impetus Digital’s cutting-edge virtual tools, comprehensive online platform, and White-Glove™ digital and strategic services to engage a group…
If you are a member of the Medical Affairs Professional Society (MAPS), you might have caught our popular webinar on how COVID-19 has impacted (and will continue to impact) live…
Dr. Gil Blander, Co-founder & Chief Scientific Officer at InsideTracker, explores consumer-driven healthcare, the use of big data and AI for creating personalized health protocols, the trillion-dollar “longevity economy,” and…
Considering its impact on our health and productivity, digital overload is clearly something that we need to take seriously.
Dr. Emilia Molimpakis, CEO & Co-founder of Thymia, shares how their platform uses video games based on neuropsychology, alongside analyses of facial microexpressions and speech, to quickly, accurately, and objectively…
Lynda Brown-Ganzert, Founder & CEO of Curatio, discusses the concept of social health prescription and the inspiration behind Curatio. She also explores questions such as how AI and “intelligent matchmaking” can be leveraged…
Aahuti Rai (Strategic Advisor, Healthcare Innovation at Four Points Consulting) & Jessica Smith (Co-Founder and CXO at SomX) discuss all things HealthTech, including the current barriers to HealthTech commercialization, holistic…
Joshua Goldberg, Co-Managing Partner at Nath, Goldberg & Meyer, discusses key intellectual property issues and pitfalls in the digital health space, the importance of international patent protection, and why it’s…
